26 September 2015 - The agenda for the 23 September 2015 TC meeting is now available. The Commission considered the following technologies:

• Alemtuzumab (Lemtrada) - new medicine
• Asparaginase (Erwinase) - new formulation
• Safinamide (Xadago) - new medicine

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-09/odj_ct_23092015_internet.pdf [French]